Literature DB >> 6349261

Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type.

G Bucht, R Adolfsson, F Lithner, B Winblad.   

Abstract

A retrospective study of 839 hospital records with various dementia diagnoses showed that 63 cases had a diagnosis of diabetes mellitus as well. None of these were found in the group of patients with senile dementia of Alzheimer type (SDAT). Oral glucose tolerance tests (OGTT) were performed in patients with SDAT, multiinfarct dementia (MID), cerebrovascular disease (CVD), hospitalized control patients (Chosp) and healthy elderly persons (Celd). Fasting blood sugar was significantly lower and the areas under the OGTT curves were significantly smaller in the SDAT group than in the CVD and the Chosp group. SDAT patients had higher insulin levels than Celd during the OGTT and on a statistically significant level 90 min after ingestion of sugar. Our findings suggest that SDAT and diabetes mellitus may not co-exist and that patients with SDAT have decreased blood sugar concentrations and elevated serum insulin levels. It is discussed whether this is an effect of the transmitter deficiencies in SDAT or may serve to explain these deficiencies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349261     DOI: 10.1111/j.0954-6820.1983.tb03756.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  28 in total

1.  [Alzheimer dementia: positive diagnosis and prevention].

Authors:  Johannes Kornhuber
Journal:  Nervenarzt       Date:  2002-05       Impact factor: 1.214

2.  Diabetes mellitus and Alzheimer's disease.

Authors:  F Lithner
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

Review 3.  Roles of AMP-activated protein kinase in Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Keshen Li; Sohel H Quazi; Bin Zhao
Journal:  Neuromolecular Med       Date:  2012-02-26       Impact factor: 3.843

4.  Central administration of alloxan impairs glucose tolerance in rats.

Authors:  M Salkovic-Petrisic; Z Lackovic; S Hoyer; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2005-10       Impact factor: 3.575

5.  Somatostatin and Alzheimer's disease.

Authors:  S Hoyer
Journal:  J Neurol       Date:  1987-05       Impact factor: 4.849

Review 6.  Alois Alzheimer revisited: differences in origin of the disease carrying his name.

Authors:  K Maurer; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-23       Impact factor: 3.575

7.  Diabetes and the elderly brain: sweet memories?

Authors:  Katherine Samaras; Perminder S Sachdev
Journal:  Ther Adv Endocrinol Metab       Date:  2012-12       Impact factor: 3.565

Review 8.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

9.  Effect of infection with the 139H scrapie strain on the number, area and/or location of hypothalamic CRF- and VP-immunostained neurons.

Authors:  X Ye; R I Carp; Y Yu; R Kozielski; P Kozlowski
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.

Authors:  A Nordberg; P Nyberg; R Adolfsson; B Winblad
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.